erythromycin

Generic: erythromycin

Labeler: orange pharmaceuticals usa llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name erythromycin
Generic Name erythromycin
Labeler orange pharmaceuticals usa llc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

erythromycin 250 mg/1

Manufacturer
Orange Pharmaceuticals USA LLC

Identifiers & Regulatory

Product NDC 73082-010
Product ID 73082-010_70c37150-654e-46d8-8931-e2e395f4bceb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213628
Listing Expiration 2026-12-31
Marketing Start 2019-10-05

Pharmacologic Class

Established (EPC)
macrolide [epc] macrolide antimicrobial [epc]
Chemical Structure
macrolides [cs]
Physiologic Effect
decreased sebaceous gland activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 73082010
Hyphenated Format 73082-010

Supplemental Identifiers

RxCUI
197650 598006
UNII
63937KV33D
NUI
N0000009982 N0000175877 N0000175935 M0028311

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name erythromycin (source: ndc)
Generic Name erythromycin (source: ndc)
Application Number ANDA213628 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED in 1 BOTTLE (73082-010-01)
  • 30 TABLET, FILM COATED in 1 BOTTLE (73082-010-30)
source: ndc

Packages (2)

Ingredients (1)

erythromycin (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "70c37150-654e-46d8-8931-e2e395f4bceb", "openfda": {"nui": ["N0000009982", "N0000175877", "N0000175935", "M0028311"], "unii": ["63937KV33D"], "rxcui": ["197650", "598006"], "spl_set_id": ["379ed8f7-b54f-495f-932e-cd0e4c691134"], "pharm_class_cs": ["Macrolides [CS]"], "pharm_class_pe": ["Decreased Sebaceous Gland Activity [PE]"], "pharm_class_epc": ["Macrolide [EPC]", "Macrolide Antimicrobial [EPC]"], "manufacturer_name": ["Orange Pharmaceuticals USA LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (73082-010-01)", "package_ndc": "73082-010-01", "marketing_start_date": "20191005"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (73082-010-30)", "package_ndc": "73082-010-30", "marketing_start_date": "20191005"}], "brand_name": "Erythromycin", "product_id": "73082-010_70c37150-654e-46d8-8931-e2e395f4bceb", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Macrolide Antimicrobial [EPC]", "Macrolide [EPC]", "Macrolides [CS]"], "product_ndc": "73082-010", "generic_name": "Erythromycin", "labeler_name": "Orange Pharmaceuticals USA LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Erythromycin", "active_ingredients": [{"name": "ERYTHROMYCIN", "strength": "250 mg/1"}], "application_number": "ANDA213628", "marketing_category": "ANDA", "marketing_start_date": "20191005", "listing_expiration_date": "20261231"}